BRIEF published on 07/09/2026 at 10:05, 3 months 27 days ago Axxam and HeartBeat.bio Form Partnership for Cardiovascular Drug Innovation New Approach Methodologies Cardiovascular Drug Discovery Cardiac Safety Assessment Human Cardiac Organoids Drug Discovery Collaboration
BRIEF published on 07/09/2026 at 10:05, 3 months 27 days ago Axxam et HeartBeat.bio s'associent pour l'innovation dans le domaine des médicaments cardiovasculaires Nouvelles Méthodologies D'approche Découverte De Médicaments Cardiovasculaires Évaluation De La Sécurité Cardiaque Organoïdes Cardiaques Humains Collaboration En Matière De Découverte De Médicaments
PRESS RELEASE published on 07/09/2026 at 10:00, 3 months 27 days ago Axxam and HeartBeat.bio partner to advance human-relevant cardiovascular drug discovery and cardiac safety assessment Axxam and HeartBeat.bio form strategic partnership to enhance cardiovascular drug discovery and safety assessment with human cardiac organoid technology Partnership Axxam HeartBeat.bio Cardiovascular Drug Discovery Human Cardiac Organoid
BRIEF published on 09/23/2025 at 10:05, 1 year 1 month ago HeartBeat.bio Collaborates with Boehringer Ingelheim on Gene Therapies Cardiovascular Health Research Collaboration Gene Therapies Heart Muscle Disorders Cardioid Platform
BRIEF published on 09/23/2025 at 10:05, 1 year 1 month ago HeartBeat.bio collabore avec Boehringer Ingelheim sur les thérapies géniques Santé Cardiovasculaire Collaboration En Recherche Thérapies Géniques Troubles Du Muscle Cardiaque Plateforme Cardioïde
PRESS RELEASE published on 09/23/2025 at 10:00, 1 year 1 month ago HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders HeartBeat.bio collaborates with Boehringer Ingelheim to develop gene therapies for genetic cardiomyopathies, addressing unmet needs in heart health Heart Health Gene Therapy Boehringer Ingelheim HeartBeat.bio Cardiomyopathies
PRESS RELEASE published on 11/02/2023 at 11:00, 3 years ago HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery
Published on 11/05/2026 at 15:20, 10 minutes ago MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors
Published on 11/05/2026 at 14:31, 59 minutes ago First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile
Published on 11/05/2026 at 14:25, 1 hour 5 minutes ago Polaris Renewable Energy Announces Q3 2026 Results
Published on 11/05/2026 at 14:20, 1 hour 10 minutes ago Polaris Renewable Energy Declares Quarterly Dividend
Published on 11/05/2026 at 14:15, 1 hour 15 minutes ago Loar Holdings Inc. Reports Q3 2026 Record Results and Upward Revision to 2026 Outlook and Full Year 2027 Outlook
Published on 11/05/2026 at 15:10, 20 minutes ago Center for Creative Leadership Names Patrick Mullane President and Chief Executive Officer
Published on 11/05/2026 at 14:58, 32 minutes ago Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 11/05/2026 at 15:01, 29 minutes ago Chiffre d'Affaires du 1er semestre de l'exercice 2026/2027
Published on 11/05/2026 at 10:16, 5 hours 14 minutes ago Accélération confirmée au troisième trimestre 2026 Tous les métiers en croissance, chiffre d’affaires en progression de +6,5 %
Published on 11/05/2026 at 10:16, 5 hours 14 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
